Merck KGaA, founded in 1668 and headquartered in Darmstadt, Germany, is a global science and technology company focused on healthcare, life sciences, and performance materials. The company operates in over 70 countries, providing innovative products and services in biopharmaceuticals, laboratory supplies, and specialty chemicals.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| MRKGR 1.63% 2079-06-25 EURMerck KGAA | Germany | 2079-06-25 | 1.625 | 6.59 |
| MRKGR 1.63% 2080-09-09 EURMerck KGAA | Germany | 2080-09-09 | 1.625 | 4.92 |
| MRKGR 2.88% 2079-06-25 EURMerck KGAA | Germany | 2079-06-25 | 2.875 | 5.70 |
| MRKGR 3.38% 2074-12-12 EURMerck KGAA | Germany | 2074-12-12 | 3.375 | 15.00 |
| MRKGR 3.88% 2054-08-27 EURMerck KGAA | Germany | 2054-08-27 | 3.875 | 3.84 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Merck KGaA began issuing bonds in 2010 to diversify its funding sources and strengthen its capital structure. Notable issuances include a €500 million bond in 2021, aimed at financing the company's strategic growth initiatives, which showcased a yield yield lower than the industry average at the time. The company regularly engages in the bond market with features such as green bonds specifically tied to sustainability projects, reflecting its commitment to environmental responsibility. In recent news, Merck KGaA's bond ratings were reaffirmed, highlighting its stable financial position and solid investment-grade status.